This inventor holds 2 USPTO granted patents. Top assignees: Amphastar Pharmaceuticals, Inc., Eli Lilly and Company. Active years: 2019-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2025
Title: Jo Jan Filip Van Betsbrugge: Innovator in Nasal Powder Formulations
Introduction
Jo Jan Filip Van Betsbrugge is a notable inventor based in Laval, Canada. He has made significant contributions to the field of pharmaceutical formulations, particularly in the treatment of hypoglycemia. With a total of 2 patents to his name, his work has the potential to impact the lives of many individuals suffering from this condition.
Latest Patents
One of his latest patents is a nasal powder formulation for the treatment of hypoglycemia. This invention provides a powder formulation containing glucagon or a glucagon analog for nasal administration. It is particularly useful in treating severe hypoglycemia. The patent also outlines a method for making this powder formulation, along with devices and methods for its application. This innovative approach could revolutionize how hypoglycemia is managed in emergency situations.
Career Highlights
Throughout his career, Jo Jan Filip Van Betsbrugge has worked with prominent companies in the pharmaceutical industry. He has been associated with Amphastar Pharmaceuticals, Inc. and Eli Lilly and Company. His experience in these organizations has undoubtedly contributed to his expertise in developing effective treatment formulations.
Collaborations
Jo Jan Filip Van Betsbrugge has collaborated with notable professionals in his field, including Sankaram B Mantripragada and Claude A Piche. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in pharmaceutical formulations.
Conclusion
Jo Jan Filip Van Betsbrugge is a distinguished inventor whose work in nasal powder formulations for hypoglycemia treatment showcases his commitment to improving patient care. His contributions to the pharmaceutical industry are commendable and hold promise for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
